Valneva Phase 2 data for Lyme disease vaccine candidate shows striking immune response
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
Clinical trials found that 77% of patients went into remission after receiving obe-cel
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Surgical site infections and antimicrobial resistance remain major challenges globally
The trial tested six injectable doses and three oral doses over as long as 36 weeks
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
The State’s PPP model has already mobilised Rs. 150 crore in core infrastructure, while Thermo Fisher has invested Rs. 90 crore in the Bioprocess Design Centre and its co-located Customer Experience Centre
Subscribe To Our Newsletter & Stay Updated